视频1 视频21 视频41 视频61 视频文章1 视频文章21 视频文章41 视频文章61 推荐1 推荐3 推荐5 推荐7 推荐9 推荐11 推荐13 推荐15 推荐17 推荐19 推荐21 推荐23 推荐25 推荐27 推荐29 推荐31 推荐33 推荐35 推荐37 推荐39 推荐41 推荐43 推荐45 推荐47 推荐49 关键词1 关键词101 关键词201 关键词301 关键词401 关键词501 关键词601 关键词701 关键词801 关键词901 关键词1001 关键词1101 关键词1201 关键词1301 关键词1401 关键词1501 关键词1601 关键词1701 关键词1801 关键词1901 视频扩展1 视频扩展6 视频扩展11 视频扩展16 文章1 文章201 文章401 文章601 文章801 文章1001 资讯1 资讯501 资讯1001 资讯1501 标签1 标签501 标签1001 关键词1 关键词501 关键词1001 关键词1501 专题2001
MAH类是什么意思?
2024-10-23 00:12:33 责编:小OO
文档


1. What does MAH mean? MAH refers to a management system where a pharmaceutical manufacturer authorizes other companies to produce its drugs. MAH is an abbreviation for Marketing Authorization Holder. MAH is different from the conventional OEM model, and the drug manufacturer must obtain approval from the National Medical Products Administration and operate under comprehensive management to gain authorization. drugs have been ensured in terms of quality and safety, giving consumers greater peace of mind.
2. What are the advantages of MAH? MAH drugs have significant cost advantages. Since pharmaceutical manufacturers do not need to build their own factories or purchase equipment, they save on labor and time costs. The quality standards are guaranteed and the production process is regulated, which helps improve the quality and consistency of drugs, giving consumers more trust and peace of mind.
3. Limitations and development of MAH. Although MAH drugs have cost advantages and quality guarantees, MAH is not an ultimate solution to pharmaceutical regulatory issues. There are still some issues to be addressed in the MAH system, such as quality regulation and responsibility tracing between different manufacturers. With the continuous reform and improvement of the National Medical Products Administration, it is believed that the MAH system will also continue to grow and be applied in more fields.

下载本文
显示全文
专题